Sling Therapeutics
Delivering New Therapies for Thyroid Eye Disease and Beyond
United States · $35.0M raised
- Business Model
- B2B
- Website
- slingtx.com
- Total Funding
- $35.0M
- Last Round
- $35.0M Series AJun 2022
- Rounds
- 1
About
Biopharmaceutical company developing oral small molecule therapies for thyroid eye disease.
Summary
Sling Therapeutics is a Biotech company based in United States. It has raised $35.0M in total across 1 round, most recently a $35.0M Series A round in Jun 2022. Investors include The Rise Fund and TPG (Growth/Rise).
Tech & App Stack
5 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...